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Summary: Cancer-associated fibroblasts (CAF) contribute to immune evasion, 
therapy resistance and metastasis of tumours. The presence of myofibroblastic CAF 
correlates with poor survival, but the mechanisms by which they are generated are 
poorly understood. Here we identify a microRNA, miR-145, which inhibits and 
reverses myofibroblast differentiation by acting in a negative feedback loop with 
WUDQVIRUPLQJ JURZWK IDFWRU ȕ 7KLV UHYHDOV D QRYHO PHFhanism underlying 
myofibroblast and CAF development which may offer therapeutic opportunities. 
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The dissemination of cancer cells to local and distant sites depends on a complex 
and poorly understood interplay between malignant cells and the cellular and non-
cellular components surrounding them, collectively termed the tumour 
microenvironment. One of the most abundant cell types of the tumour 
microenvironment is the fibroblast, which becomes corrupted by locally derived cues 
such as TGF-ȕ DQG acquires an altered, heterogeneous phenotype (cancer-
associated fibroblast, CAF) supportive of tumour cell invasion and metastasis. Efforts 
to develop new treatments targeting the tumour mesenchyme are hampered by a 
poor understanding of the mechanisms underlying the development of CAF. 
Here we examine the contribution of microRNA to the development of 
experimentally-derived CAF and correlate this with changes observed in CAF derived 
from tumours. Exposure of primary normal human fibroblasts to TGF-ȕUHVXlted in 
the acquisition of a myofibroblastic CAF-like phenotype. This was associated with 
increased expression of miR-145, a miRNA predicted in silico to target multiple 
components of the TGF-ȕVLJQDOLQJ pathway. miR-145 was also over-expressed in 
CAF derived from oral cancers. Over-expression of miR-145 blocked TGF-ȕ-
induced myofibroblastic differentiation and revert CAF towards a normal fibroblast 
phenotype.  
We conclude that miR-145 is a key regulator of the CAF phenotype, acting in a 
negative feedback loop to dampen acquisition of myofibroblastic traits, a key feature 
of CAF associated with poor disease outcome.  
 
 
Introduction 
It is becoming increasingly apparent that interactions between malignant cells and 
Abstract 
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the cells and other constituents of the tumour microenvironment play a key role in 
disease outcome (1). Fibroblasts are one of the most numerous cells in the tumour 
microenvironment and act to modulate both cancer cell behaviour and the host 
immune responses by remodelling the extracellular matrix (ECM) and secreting a 
wealth of soluble factors able to interact with nearby cellular receptors via cell 
autonomous and subservient mechanisms (2).  The phenotypes of the fibroblasts 
surrounding a tumour (collectively termed cancer associated fibroblasts; CAF) are 
complex and varied, but certain CAF features are strongly associated with cancer 
cell dissemination and poor outcome (3). The best characterized of these is the 
SUHVHQFH RI µP\RILEUREODVWLF¶ &$) cells expressing alpha smooth muscle actin 
Į60$ ZKLFK DW OHDVW VXSHUILFLDOO\ UHVHPEOH P\RILEUREODVWV IRXQG WUDQVLHQWO\ LQ
healing wounds (4). Myofibroblastic CAF are contractile, secretory cells that generate 
an altered extracellular matrix and are generally accepted to contribute to an 
extracellular milieu supportive of cancer cell invasion and metastasis (2). The 
SUHVHQFHRIĮ60$-rich CAF is correlated with poor outcome in a number of cancers, 
suggesting a key role in disease progression (3,5±7). The source of myofibroblastic 
CAF is controversial but at least some are likely to arise from differentiation (or 
µDFWLYDWLRQ¶ RI UHVWLQJ ILEUREODVWV SURYRNHG E\ VLJQDOV VXFK DV 7*)-ȕ UHOHDVHG
from cancer cells and inflammatory cells recruited to the tumour microenvironment 
(8).  
Despite the wealth of data supporting a role for CAF in contributing to tumour 
metastasis, little is known of the mechanisms underlying CAF development from 
resident stromal fibroblasts. Here, we applied an in silico approach to identify a 
microRNA, miR-145, found predominantly in mesenchymal cells (9), putatively able 
to target components of the TGF-ȕVLJQDOOLQJSDWKZD\:HVXEVHTXHQWO\H[DPLQHG
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the effects of this microRNA on the phenotype of normal fibroblasts, myofibroblasts 
and CAF. Expression of miR-145 was induced by exposure of normal fibroblasts to 
TGF-ȕ DQG ZDV DOVR HOHYDWHG LQ &$) 2YHUH[SUHVVLRQ RI PL5-145 inhibited and 
reversed the development of myofibroblastic traits and stromal-epithelial interactions, 
indicating the existence of a miR-145/TGF-ȕ QHJDWLYH IHHGEDFN ORRS LQ
myofibroblasts and CAF. This suggests the possibility of exploiting this 
therapeutically to reduce pro-tumourigenic traits of stromal fibroblasts.  
 
Materials and methods 
 
Routine tissue culture: All FHOOVZHUHURXWLQHO\FXOWXUHGLQ'XOEHFFR¶VPRGLILFDWLRQRI
(DJOH¶VPHGLXP '0(0VXSSOHPHQWHGZLWK YY IRHWDO ERYLQH VHUXP )%6
and 2 mM L-glutamine, without antibiotics at 37 °C with 5% (v/v) CO2. Primary 
fibroblasts were used within 3-9 passages.  For TGF-ȕ WUHDWPHQW RUDO ILEUREODVWV
were seeded at 250,000 cells per well in a six well plate, allowed to settle before 
being serum starved for 24 h before treatment with 5 ng/ml TGF-ȕIRU-96 h (as 
indicated in individual figure legends) in serum free DMEM supplemented with 2 mM 
L-glutamine.  
 
Primary normal oral fibroblasts (NOF) were isolated from informed consenting 
patients undergoing wisdom tooth extraction at the Charles Clifford Dental Hospital 
(Sheffield Research Committee ethics permission 09/H1308/66) (10). CAF were 
isolated from oral squamous cell carcinoma (OSCC) of consenting patients at the 
University of Campinas (CAFC) and the University of Glasgow prior to the 
introduction of current ethical requirements (CAF1-10). CAF2, CAF4, CAF8, CAF9, 
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and CAF10 were obtained from  GU-SCC (genetically unstable-SCC) biopsies known 
to contain tumourigenic SCC keratinocytes whereas GS-SCC CAF (genetically 
stable-SCC), CAF1, CAF3, CAF5, CAF6 & CAF7 were obtained from GS-SCC 
biopsies (11±13), In addition to NOF cultures, normal human oral fibroblast cultures 
NHOF-1 and NHOF-5 were obtained from the University of Peridanya, Kandy, Sri 
Lanka (14). Human primary dermal fibroblasts, HDF1 (Promocell) and HDF2 
(09/H1308/66)  
were kind gifts from Dr Simon Whawell and Prof Sheila MacNeil respectively.  H357, 
a cell line isolated from tongue OSCC (15), was obtained from ATTCC and cell 
identity was confirmed by satellite tandem repeat (STR) analysis of cells within 10 
passages.  
The primary fibroblasts used in this study were isolated from separate institutions 
using adapted protocols. A full table of the cells used in this study and the isolation 
methods are given in table 1. 
Fibroblast isolation: Primary fibroblasts were isolated from oral biopsies as previously 
described (Hearnden et al., 2009), where the keratinocytes were removed by 
incubation with 0.1% (w/v) Difco trypsin (BD Biosciences) at 4°C overnight and 
subsequently scraped with a scalpel to collect the epithelium. The remaining tissue 
was finely minced and enzymatically digested with collagenase (0.5% (v/v)) at 37°C 
with 5 % (v/v) CO2 overnight. The collagenase suspension was centrifuged at 2000 
rpm for 10 min to retrieve the NOFs. NOFs were initially cultured with routine culture 
media containing 0.625 µg/ml amphotericin B and 100 i.u./ml penicillin and 100 µg/ml 
streptomycin, before removing the antibiotics for experimental use.  
Alternatively, in the case of fibroblasts provided by Prof E. Ken Parkinson (QMUL, 
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UK), issue specimens were finely cut, washed with foetal bovine serum and 
incubated for 30-40 min in a dry atmosphere at 37°C. A small amount of DMEM plus 
10 % (v/v) FBS (~ 2 ml) was added to cover the tissue, then the cells were left to 
grow as explants for 3 days at 37°C. Fibroblasts were selectively cultured in routine 
culture media (DMEM plus 10% (v/v) FBS and 2mM L-glutamine), where cultures 
contained keratinocytes, these were removed by the addition of 0.02 % (v/v) EDTA 
for 30 s, followed by an equal volume of PBS (Stanley et al., (1979) and Prime e  al., 
(1990)). 
In the case of fibroblasts provided by Prof R Coletta (University of Campinas, Brazil), 
tissue samples were washed three times with PBS, finely cut and placed in 1 ml 
DMEM plus 10 % FCS and antibiotics at 37oC in a humidified atmosphere of 5 % 
(v/V) CO2. Cell outgrowth was observed until confluence while changing the media 
every 2-3 days. Cells were trypsinised and seeded at low densities to isolate 
individual myofibroblast clones (Sobral et al, 2011). 
 
Transfection: Synthetic oligonucleotide premiRs (premiR-143, premiR-145 or 
negative premiR; 50 nM) and siRNAs (versican siRNA and negative siRNA; 50 nM) 
(all Life Technologies) were transiently transfected into the primary oral fibroblasts 
using Oligofectamine (Life Technologies) in Opti-MEM (Life Technologies). 
Transfection was performed before or after TGF-ȕ WUHDWPHQW &RQGLWLRQHG PHGLD
(serum-free DMEM supplemented with 2 mM L-glutamine) were collected after 24 h 
for subsequent use in transwell migration assays. 
 
Immunocytochemistry: 7R YLVXDOLVH Į60$ VWUHVV ILEUHV  ILEUREODVWV ZHUH
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seeded on glass coverslips in six-well plates. After treatments/transfections they 
were fixed with methanol for 10 min, permeabilised by using 4mM sodium 
deoxycholate and incubated with a FITC-conjugated anti-KXPDQ Į60$ PRXVH
antibody (clone 1A.4; 1:100; Sigma-Aldrich Cat#F3777, RRID:AB_476977) for 12 h 
at 4 °C, following blocking of non-specific binding sites in 2.5% (w/v) bovine serum 
albumin (BSA) in phosphate buffered saline (PBS) for 30 min. Coverslips were 
washed twice with PBS, mounted using mounting media containing 4',6-diamidino-2-
phenylindole (DAPI; Vectorshield), viewed using a Ziess Axioplan 2 fluorescence 
light microscope at 40x and imaged using Proplus 7.0.1 image software. 
 
Contractility assay: Fibroblast-populated collagen gels were prepared as previously 
described (16) using transiently transfected or un-modified normal human primary 
oral fibroblasts as described in individual figure legends. 
 
Quantitative Real Time PCR: Total RNA was extracted from pelleted fibroblasts 
XVLQJWKH51HDV\4LDJHQNLWDFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV51$ZDV
quantified using a Nanodrop 1000 spectrophotometer (Thermo). RNA (100 ng) was 
reverse transcribed using the high capacity cDNA Reverse Transcription kit (Applied 
%LRV\VWHPV DFFRUGLQJ WR WKHPDQXIDFWXUHU¶VSURWRFRO6SHFLILFPDWXUHPLFUR51$V
were reverse transcribed from 10 ng RNA using specific Taqman reverse 
transcription microRNA probe/primers for mature miR-143, miR-145 and the small 
nuclear RNA RNU48 as a reference (Applied Biosystems). Total or specific miRNA-
derived cDNA was subsequently used as a template for SYBR green or Taqman real 
time quantitative PCR amplification (7900HT fast Real Time-PCR system, Life 
Technologies). Sequences of primers used for SYBR analysis (Sigma) were as 
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follows: 8 )RUZDUG ) ¶ &7&*&77&**&$*&$&$¶ 8 5HYHUVH 5
¶$$&*77&$&*$$777*&*7¶Į60$)¶*$$*$$*$**$&$*&$&7*¶Į60$
5 ¶7&&&$77&&&$&&$7&$&¶ ILEURQHFWLQ-1 with extra domain A (FN1-EDA) 
¶7**$$&&&$*7&&$&$*&7$77¶ )1-EDA R 
¶*7&77&7&&77*****7&$&&¶ FROODJHQ $ &2/$ )
¶*7**&&$7&&$*&7*$&&¶ &2/$ 5
¶$*7**7$**7*$7*77&7***$*¶FRQQHFWLYHWLVVXHJURZWKIDFWRU&7*))¶
***$$$7*&7*&*$**$*7¶&7*)5 
¶$**7&77**$$&$**&*&7&¶PDWUL[PHWDOORSURWHLQDVH003)¶ 
$$7$$77&&*&77&&$***&$&$7&& ¶ 003 5 ¶
77$77*&**7&*7$*7&&7&$*7**7 ¶ 9HUVLFDQ LVRIRUP VSHFLILF 7DTPDQ
probes (Applied Biosystems) were used to assess the expression of V0 and V1 
versican isoform transcripts. RelaWLYH H[SUHVVLRQ ZDV FDOFXODWHG XVLQJ WKH ǻǻ&7
method (17) normalised to endogenous controls U6 (SYBR green), or RNU 48 
(Taqman). All qPCR was carried out according to best-practice MiQE guidelines (18). 
 
Immunoblotting: Total protein lysates were prepared in radio-immunoprecipitation 
assay (RIPA) buffer supplemented with complete mini protease inhibitor cocktail 
(Roche) and benzonuclease (Sigma). Protein lysates (20-30 µg) were resolved by 3-
8% (v/v) SDS-polyacrylamide gel (Life Technologies) electrophoresis (SDS-PAGE) in 
Tris-acetate buffer (Life Technologies). Proteins were transferred onto a 
nitrocellulose membrane (Millipore) by wet transfer or iBlot dry transfer (Invitrogen), 
and incubated in blocking solution (5% (w/v) milk powder and 3% (w/v) bovine serum 
albumin (BSA) in Tris buffered saline (TBS) with 0.05% (v/v) Tween 20 (TBS-T)) for 1 
h. Mouse monoclonal  anti-KXPDQ Į60$ FORQH $ 6LJPD-Aldrich Cat#A2547, 
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RRID:AB_476701), goat polyclonal anti-human versican (R&D systems), or 
monoclonal rabbit anti-human GAPDH (Sigma-Aldrich Cat#G9295, 
RRID:AB_1078992) antibodies were diluted (1:1000) in blocking solution and 
incubated with membranes at 4°C overnight. The membrane was washed 3 x 5 min 
with TBS-T, and subsequently incubated with a horseradish peroxidase-conjugated 
(HRP) secondary antibody (1:3000 in blocking solution), for 1 h at ambient 
temperature. The membrane was washed 3 x 10 min in TBS-T, and developed using 
enhanced chemiluminescence (Pierce).  
 
Migration and Invasion assays: Conditioned media collected from transfected and 
TGF-ȕ  QJPO WUHDWHG ILEUREODVWV ZHUH FHQWULIXJHG DW  [ g and the 
supernatant was placed into the bottom of a well of a 24-well plate. H357 cells, 
previously serum-starved for 24 h, were resuspended into 0.1% (w/v) BSA in DMEM 
supplemented with L-glutamine (2 mM) and seeded at a density of 100,000 cells/well 
into the top of a transwell chamber (BD Biosciences). Transwells were coated with 
0DWULJHOȝJPO&RUQLQJWRDVVHVVFHOOLQYDVLRQ&HOOVZHUHDOORZHGWRPLgrate 
for 36 h at 37°C and 5% (v/v) CO2 in the presence of 1 mg/ml mitomycin C, to inhibit 
cell proliferation. Transwell chambers were swabbed to remove non-migrated cells in 
the top of the chamber and fixed in methanol for 10 min. Migrated cells were stained 
with 0.1% (w/v) crystal violet and imaged at four randomly selected fields of view per 
transwell at 40x magnification using a light microscope. Migrated cells were then 
counted using ImageJ.  
 
Statistical analyses: A paired two-WDLOHGVWXGHQW¶VW-test was used to test for statistical 
significance. A Mann Whitney U test (performed in GraphPad Prism 6) was used to 
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assess significance in differential gene expression in NOFs and CAF.  All data 
presented is n=3, unless otherwise stated. N=3 refers to biological replicates from 
the same fibroblast strain, however each experiment has been repeated in at least 2 
strains and a representative figure was selected and shown for conciseness.  
 
Results 
TGF-ȕVWLPXODWHVSUR-tumourigenic myofibroblast transdifferentiation 
The ability of TGF-ȕWR LQGXFHP\RILEUREODVW WUDQVGLIIHUHQWLDWLRQRISULPDU\KXPDQ
fibroblasts was examined using several established markers of the myofibroblast 
phenotype (19±23). Treatment of oral fibroblasts with TGF-ȕQJPOresulted in a 
time-GHSHQGHQW LQFUHDVH LQ WKHH[SUHVVLRQRIĮ60$ YHUVLFDQ 9&$19 LVRIRUP
and fibronectin 1 extra domain A (FN1-EDA) transcripts (Fig 1a-c), with a 
FRUUHVSRQGLQJ LQFUHDVH LQ Į60$ SURWHLQ OHYHOV DQG WKH DSSHDUDQFH RI Į60$-rich 
stress fibres (Fig 1d&e). This was associated with increased ability to contract 
collagen I lattices (Fig 1f), in keeping with previous reports (22). Conditioned medium 
from TGF-ȕ-induced myofibroblasts promoted more cancer cell migration and 
invasion than medium from untreated fibroblasts (Fig 1g&h). It is noteworthy that not 
all the different cultures of primary fibroblasts tested, obtained from different patients, 
responded equally to TGF-ȕ)LJ6 
 
MicroRNA-145 is upregulated during myofibroblast transdifferentiation 
In order to begin to examine the molecular mechanisms underlying the TGF-ȕ-
induced acquisition of a pro-tumourigenic, myofibroblastic phenotype by primary 
fibroblasts, we carried out an in silico analysis to identify miRNA predicted to target 
components of the TGF-ȕVLJQDOOLQJSDWKZD\XVLQJDYDULHW\RIRQOLQHDOJRULWKPV
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including DIANA (http://diana.cslab.ece.ntua.gr/). One of the candidate miRNA 
identified using this approach, miR-145, is predicted or functionally demonstrated in 
the literature to have numerous targets or putative targets in the TGF-ȕ SDWKZD\
(Fig 2a), and was upregulated in response to TGF-ȕWUHDWPHQWLQDQXPEHURI12)
and CAF (isolated from patients with oral squamous cell carcinomas (14)) cultures 
analysed (Fig 2b&c) but with heterogeneity in response between different cultures. 
Having identified a putative role for miR-145 in fibroblast responses to TGF-ȕZH
next analysed the expression levels of mature miR-145 in a panel of ten NOF and 
ten CAF miR-145 expression was statistically significantly higher in CAF than in 
normal oral fibroblasts (Fig 2d).  
 
miR-145 inhibits myofibroblast differentiation in response to TGF-ȕ 
In order to examine the effect of miR-145 on myofibroblast differentiation, a synthetic 
miRNA functionally mimicking mature miR-145 or a control, non-targeting miRNA, 
were transfected into primary oral fibroblasts and the effect on markers of the 
myofibroblastic phenotype was examined. Over-expression of miR-145 (Fig 3a) 
resulted in an almost complete abolition of the ability of TGF-ȕ WR LQGXFH Į60$
transcript levels (Fig 3b) and a reduction of TGF-ȕ-LQGXFHGĮ60$SURWHLQOHYHOVDV
GHWHUPLQHGE\ LPPXQREORWWLQJ)LJF1RFKDQJH LQ WKHEDVDO OHYHORIĮ60$ZDV
observed in response to miR-145 over-expression in the absence of TGF-ȕ
Overexpression of miR-143, a miRNA co-expressed with miR-145 as part of a 
ELFLVWURQLF FOXVWHU  UHVXOWHG LQ D VPDOO GHFUHDVH LQ WKH H[SUHVVLRQ RI Į60$
WUDQVFULSWEXWKDGQRHIIHFWRQĮ60$SURWHLQOHYHOV)LJE	F,QNHHSLQJZLth these 
findings, we observed a modest, but significant, reduction in the ability of fibroblasts 
to contract collagen gels in response to TGF-ȕ FRPSDUHG WR FRQWUROV )LJ G
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6LPLODU UHVXOWV ZLWK UHJDUGV WR Į60$ H[SUHVVLRQ ZHUH REWDLQHG XVLQJ GHUPDO
fibroblasts, suggesting the effects of miR-145 are not tissue specific (Fig 3e,f).  
We next examined the ability of miR-145 to influence extracellular matrix production, 
alterations of which are associated with myofibroblastic CAF (19,22,23,25). 
Heterologous over-expression of miR-145 was found to significantly and markedly 
decrease the expression of transcripts derived from a number of genes encoding 
components of the extracellular matrix, including FN1-EDA, connective tissue growth 
factor (CTGF), COL1A1, MMP2 and both variants of VCAN expressed in oral 
fibroblasts (VCAN V0 and V1), and to block the upregulation of these genes in 
response to TGF-ȕ)LJXUHD-f). The down-regulation of VCAN was also observed 
at the protein level, as determined by immunoblotting (Fig 4g) with the level of 
knockdown approaching that achieved by VCAN-specific siRNA (Fig 4g).  Over-
expression of miR-143, previously reported to regulate VCAN expression (26), had 
no effect on either VCAN transcript or protein levels (Fig 4g). Over-expression of 
miR-145 attenuated the ability of myofibroblasts to stimulate cancer cell migration 
and invasion in a paracrine manner (Fig 4h&i). Similar effects of miR-145 on the 
fibroblast phenotype were obtained with dermal fibroblasts (Fig 4j&k). 
 
miR-145 regulates the CAF phenotype 
Having established the ability of miR-145 to inhibit the acquisition of a CAF-like 
myofibroblastic phenotype in normal oral fibroblasts, we next examined its effects in 
CAF. Over-expression of miR-145 in CAF resulted in a decrease in both basal and 
7*)ȕ-LQGXFHG Į60$ &2/$ DQG )1-EDA transcript levels (Fig 5a-c) and a 
significant reduction in the ability of TGF-ȕ WR LQGXFH WKH IRUPDWLRQ RI Į60$-rich 
stress fibres (Fig 5d). As observed in normal fibroblasts, miR-145 overexpression 
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was able to inhibit TGF-ȕ-LQGXFHGĮ60$OHYHOVLQDOOWKH&$)FXOWXUHVDQDO\VHG)LJ
5e and Fig S2A-C), and reduced both basal and TGF-ȕ-induced VCAN protein 
expression (Fig 5e). Over-expression of miR-145 in CAF inhibited paracrine 
stimulation of cancer cell migration in two of the four CAF cultures tested (Fig 5f). 
Each of the four CAF cultures used had a higher endogenous miR-145 expression 
relative to average NOF miR-145 levels (Table S1).  
To further examine the regulation of CAF phenotype by miR-145 we investigated a 
possible correlation between miR-145 expression levels and, both endogenous and 
TGF-ȕ-LQGXFHGĮ60$JHQHH[SUHVVLRQ:HIRXQGDVLJQLILFDQWSRVLWLYHFRUUHODWLRQ
between endogenous miR-DQGĮ60$H[SUHVVLRQLQERWK12)DQG&$)FXOWXUHs 
(R2=0.7387, p<0.001; Fig S3a). However, it should be noted, if the fibroblast culture 
with the highest level of Į60$ ZDV RPLWWHG IURP WKH UHJUHVVLRQ DQDO\VLV WKH
correlation was no longer significant (R2 =0.06846, p= 0.2278). There was also a 
trend WRZDUGV D SRVLWLYH FRUUHODWLRQ ZKLFK GLGQ¶W KRZHYHU UHDFK VLJQLILFDQFH
between CAF endogenous miR-145 levels and the magnitude of the TGF-ȕ-induced 
Į60$)LJ6E  
 
miR-145 rescues the CAF phenotype 
In order to examine whether these findings would hold therapeutic potential we 
tested the ability of miR-145 to rescue the CAF phenotype. TGF-ȕ WUHDWHG 12)
which were subsequently transfected with miR-145 mimic, showed markedly reduced 
H[SUHVVLRQ RI &$) PDUNHUV Į60$ &2/$ DQG )1-EDA (Fig 6a-d) and also a 
significant reduction in versican V0 and V1 expression (Fig 6e&f). The same reversal 
of TGF-ȕ LQGXFHG&$)SKHQRW\SHZDVVHHQ LQGHUPDOILEUREODVWV +'))LJJ-l). 
The extent of miR-145 overexpression was assessed by RT-qPCR in NOFs and 
Downloaded from https://academic.oup.com/carcin/advance-article-abstract/doi/10.1093/carcin/bgy032/4913311
by University of Sheffield user
on 07 March 2018
Ac
ce
pte
d M
an
us
cri
pt
 
 
 
HDFs (Fig S4a&b).  
 
Discussion 
The molecular mechanisms underlying the development of CAF from resident 
stromal fibroblasts are poorly understood, hampering the development of stromally-
directed therapies. Here we identify miR-145 as a key regulator of the differentiation 
of myofibroblastic CAF from resting fibroblasts. We provide evidence that miR-145 
levels are elevated in the majority of CAF isolated from oral squamous cell 
carcinomas compared to normal resting oral fibroblasts, and that induction of a 
myofibroblastic CAF-like phenotype in vitro results in induction of miR-145 
expression. Furthermore, we show that miR-145 suppresses cytoskeletal and 
matricellular markers of myofibroblast activation, and paracrine stimulation of cancer 
cell migration and invasion, suggesting miR-145 up-regulation may serve to limit pro-
tumourigenic, myofibroblastic differentiation in the tumour microenvironment. 
Whilst tumour-suppressive effects of miR-145 have been described in both tumour 
cells and fibroblasts (27±30), two recent studies suggested that miR-145 is restricted 
to, or at least significantly enriched in, cells of mesenchymal origin (9,31). In keeping 
with this, functions have been ascribed to miR-145 in a variety of mesenchymal cells, 
including smooth muscle cells and fibroblasts (32±36). In both of these cell types 
miR-145 is most commonly described as having the ability to promote differentiation, 
although a very recent study demonstrated that the effects of miR-145 on the 
vascular smooth muscle cell (VSMC) phenotype are context-specific, and that miR-
145 is able to inhibit responses to TGF-ȕOLPLWLQJWKHGLIIHUHQWLDWLRQRI960&V
This is consistent with our findings, in which we observe miR-145 levels to increase 
in response to TGF-ȕEXWWRGRZQ-regulate numerous target genes induced by TGF-
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ȕWKHUHE\LQKLELWLQJWKHGHYHORSPHQWRIDP\RILEUREODVWLFSKHQRW\SH,QFRQWUDVWWR
other studies (33±35), however, we found no evidence of miR-145 having the ability 
to induce myofibroblast markers in the absence of TGF-ȕLQGHHGLQWXPRXU-derived 
CAF, miR-145 reproducibly reduced the basal levels of both cytoskeletal and 
matricellular myofibroblast markers. These conflicting results may be the result of 
species differences or the use of embryonic versus adult fibroblasts, but also 
suggests a degree of complexity characteristic of mechanisms regulating the actions 
of TGF-ȕ OLNHO\ UHIOHFWLQJ WKH QHHG WR WXQH UHVSRQVHV WR WKH G\QDPLF tissue 
microenvironment.  It is noteworthy that our in silico analysis and unpublished data 
(de Oliveira et al, data not shown) indicates that miR-145 may target the receptors 
and signaling components of other TGF-ȕ-related molecules, including activin A and 
bone morphogenetic proteins (BMPs), suggesting miR-145 may play a role in 
regulating cellular responses to these stimuli in addition to TGF-ȕZHVSHFXODWHWKDW
this pleiotropy may contribute to the complex and contradictory functions reported for 
miR-145 in fibroblasts and smooth muscle cells. 
TGF-ȕ VLJQDOOLQJ ZLWKLQ VWURPDO ILEUREODVWV SOD\V D FUXFLDO UROH LQ GHWHUPLQLQJ
fibroblast responses to local cues such as ECM remodeling, and as such is subject 
to multiple layers of regulation (reviewed in (37)). Dysregulation of the TGF-ȕ
pathway, such as TGF-ȕRYHUH[SUHVVLRQDQG ORVVRI IXQFWLRQRI7*)ȕ UHFHSWRU ,,
(TGF-ȕ5,, LQ ILEUREODVWV SURPRWHV WXPRXULJHQHVLV LQ DGMDFHQW HSLWKHOLDO FHOOV DQG
malignant progression (38±40). A variety of mechanisms exist to regulate TGF-ȕ
signalling, including negative feedback, exemplified by the role of SMAD7, which is 
induced by TGF-ȕ EXW OLPLWV LWV GRZQVWUHDP HIIHFWV E\ QHJDWLYHO\ UHJXODWLQJ WKH
canonical signaling pathway via SMAD3/4 (41). Our data suggests miR-145 function 
in a similar manner by negatively regulating the responses of stromal fibroblasts to 
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TGF-ȕ 
Myofibroblastic differentiation is a complex process regulated by both intrinsic and 
extrinsic cues. Among extrinsic cues, the ECM plays a prominent role, both through 
interaction of cells with individual components and by mechanical forces imposed by 
the ECM. In this study, we provide evidence that miR-145 reduces the synthesis of a 
variety of ECM components in the presence and absence of TGF-ȕ:KDWLs yet to 
be determined, however, is whether these are direct or indirect targets of miR-145. 
Of those targets studied, only CTGF is reported to be directly targeted by miR-145 
(42); we are currently seeking to validate this in primary fibroblasts. miR-145 has 
several documented targets in the TGF-ȕSDWKZD\LQFOXGLQJ60$'DQG7*)-
ȕ5,,  GRZQ-regulation of which may influence the production of ECM 
components. We propose that miR-145 regulates responses to TGF-ȕE\WDUJHWLQJ
multiple components of the pathway, possibly differentially in response to yet 
undetermined additional context-specific cues. In the tumour microenvironment, this 
confers on miR-145 the ability to reduce the myofibroblastic, pro-tumourigenic CAF 
phenotype. 
Here we have outlined a key role for mesenchymal miR-145 in a TGF-ȕIHHGEDFN
loop in stromal fibroblasts. Up-regulated by TGF-ȕ PL5-145 is able to dampen 
TGF-ȕ PHGLDWHG P\RILEURblast transdifferentiation and consequential pro-
tumourigenic effects in fibroblasts.  This raises the possibility that miR-145 could be 
exogenously targeted to the tumour microenvironment to attenuate the pro-
tumourigenic myofibroblastic phenotype of CAF. It may also hold promise in other 
contexts in which myofibroblasts play a role, such as fibrotic disorders. miRNA-
mediated therapies are currently in clinical trials (reviewed in (44)) and recent 
developments in miRNA delivery techniques have realised the possibility of 
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specifically delivering miRNAs to specific tissue microenvironments (45).  
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Figure legends 
Figure 1. TGF-ȕ LQGXFHV P\RILEUREODVWLc features in primary human 
fibroblasts. Primary fibroblasts (a-c: NOF2, d: NOF3, e-f: NOF2, g-i: NOF1) were 
treated with TGF-ȕQJPORUVHUXPIUHH'0(0IRU-96 h as indicated. RNA 
was extracted, reverse transcribed and subjected to qPCR to determine the 
WUDQVFULSW OHYHOVRIĮ60$D9&$19ERU)1-EDA (c). Total cell lysates were 
SUHSDUHGDQGLPPXQREORWWHGIRUĮ60$G)ROORZLQJWUHDWPHQWZLWK7*)-ȕIRU
KFHOOVZHUH IL[HG LQPHWKDQRODQGĮ60$YLVXDOL]HGXVLQJD),7&-conjugated anti-
Į60$Dntibody (e). The ability of fibroblasts treated with TGF-ȕIRUKWRFRQWUDFW
collagen 1 was examined compared to serum free DMEM treated controls (f). 
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Conditioned medium collected from cells exposed to TGF-ȕIRUKZDVXVHGLQD
transwell assay to assess the migration (g) or invasion through Matrigel (h) of H357 
cancer cells. ****p<0.0001, ***p<0.001, **p<0.01 assessed using a paired, two tailed 
VWXGHQW¶VW-test. n=3, biological replicates in fibroblast strain indicated above.  
 
Figure 2. miR-145 has multiple putative targets in TGF-ȕ VLJQDOLQJ SDWKZD\V
and is up-regulated by TGF-ȕ Analysis of potential targets of miR-145 using 
DIANA reveals a number of putative targets in the TGF-ȕVLJQDOOLQJSDWKZD\DVZHOO
as other genes associated with myofibroblast differentiation (a). NOF (NOF1-4) were 
serum starved for 24 h before being exposed to TGF-ȕQJP/RUYHKLFOHIRU
h. Levels of miR-145 were analysed by conventional qPCR in 10 independent NOF 
cultures (NOF1-10) (c) and 4 independent CAF cultures (CAF1-10) (c). ****p<0.0001, 
S S EF XVLQJ D SDLUHG WZR WDLOHG VWXGHQW¶V W-test, and a Mann 
Whitney U test (c). N=3, biological replicates (b). 
 
Figure 3. miR-145 overexpression inhibits myofibroblast differentiation.  
Proliferating NOF (NOF1) were transfected with 50 nM synthetic premiR-143, 
premiR-145 or a control, non-targeting premiR (negative premiR), incubated for 24 h 
before being exposed to TGF-ȕQJP/RUVHUXPIUHH'0(0FRQWUROIRUDIXUWKHU
48 h. RNA was extracted and resulting cDNA subjected to qPCR for mature miR-145 
DRUĮ60$E7RWDOFHOOXODUO\VDWHSURWHLQIURPFHOOVWUDQVIHFWHGDVGHVFULEHGZDV
LPPXQREORWWHGIRUĮ60$FDGGLWLRQDOO\WUDQVIHFWHGFHOOV12)-4; data combined) 
were seeded into collagen I gels and their ability to contract the gels in following 
treatment with TGF-ȕQJP/RUYHKLFOHFRQWUROIRUKGHWHUPLQHGG+XPDQ
dermal primary fibroblasts (HDF) were transfected with miR-145 and treated with 
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TGF-ȕDVDERYHĮ60$WUDQVFULSW OHYHOVZHUe assessed by qPCR (e) and protein 
by immunoblotting (f) ****p<0.0001, ***p<0.001, **p<0.01 using a paired, two tailed 
VWXGHQW¶VW-test. All n=3, biological replicates in fibroblast strain indicated above. 
. 
Figure 4. miR-145 alters ECM deposition by fibroblasts. Proliferating NOF ((a-f): 
NOF1, (g): NOF4, (h-i): NOF1) were transfected with 50 nM synthetic premiR-145 or 
a control, non-targeting premiR (negative premiR), incubated for 24 h before being 
exposed to TGF-ȕQJP/RUVHUXPIUHH'0(0FRQWUROIRr a further 48 h. RNA 
was extracted and resulting cDNA subjected to qPCR for FN1-EDA (A), CTGF (B), 
COL1A1 (C), MMP2 (D), and VCAN transcripts V0 and V1 (E, F).  Total cellular 
lysate proteins from cells transfected as described, or transfected for 24 h prior to 
TGF-ȕ WUHDWPHQW ZLWK HLWKHU PL5-145 or a non-targeting miRNA, siRNA targeting 
VCAN or a non-WDUJHWWLQJVL51$ZHUHLPPXQREORWWHGIRU9&$1DQGUHSUREHGIRUȕ-
actin as a loading control (G). Conditioned medium was collected after 24 h 
incubation from NOF transfected as described and treated with TGF-ȕIRUK7KH
media was changed for fresh low serum medium before conditioned medium was 
added to the lower chamber of a transwell assay, and H357 cells in reduced serum 
medium added to the top of the insert. Cells migrating across the insert were counted 
(H). The same procedure was followed with matrigel present in the insert (I). Human 
dermal primary fibroblasts (HDF) were transfected with miR-145 and treated with 
TGF-ȕ DV DERYH )1-EDA1 transcript levels were assessed by qPCR (J) and 
versican protein by immunoblotting (K).  ****p<0.0001, ***p<0.001, **p<0.01 using a 
SDLUHG WZR WDLOHG VWXGHQW¶V W-test. All n=3, biological replicates in fibroblast strain 
indicated above. 
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Figure 5. miR-145 regulates the CAF phenotype. Proliferating CAF (CAF1) were 
transfected with 50 nM synthetic premiR-145 or a control, non-targeting premiR 
(negative premiR), incubated for 24 h before being exposed to TGF-ȕQJP/RU
serum free DMEM control for a further 48 h. RNA was extracted and resulting cDNA 
VXEMHFWHG WR T3&5 IRU Į60$ $ &2/$ % DQG )1-EDA (C). Following 
treatment with TGF-ȕIRUK&$)ZHUH IL[HG LQPHWKDQRODQGĮ60$YLVXDOL]HG
using a FITC-conjugated anti-Į60$DQWLERG\'RUWRWDOFHOOO\VDWHVZHUe prepared 
DQGLPPXQREORWWHGIRUĮ60$DQG9&$1ȕ-actin served as a loading control (E). 4 
CAF cultures (CAF1-3, CAFC)) were transfected with miR-145 mimic or non-
targeting control and conditioned medium collected before being added to the lower 
chamber of a transwell assay, and H357 cells in reduced serum medium added to 
the top of the insert (schematic, F). Cells migrating across the insert were counted . 
SSSXVLQJDSDLUHGWZRWDLOHGVWXGHQW¶VW-test. All n=3, 
biological replicates in fibroblast strain indicated above, except (f) where each the 
migration assay for each CAF was performed twice. 
 
Figure 6. miR-145 rescues CAF phenotype. Proliferating NOF (NOF2; A-F) and 
HDF (G-L) were treated with TGF-ȕQJP/IRUKDQG subsequently transfected 
with 50 nM synthetic premiR-145 or a control, non-targeting premiR (negative 
premiR), incubated for a further 24 h. RNA was extracted and resulting cDNA 
VXEMHFWHG WR T3&5 IRU Į60$ $ DQG * &2/$ * DQG , )1-EDA (D and J) 
versican V0 (E and K) and versican V1 (F and L). Following treatment and 
transfection, total protein lysates were prepared from NOF and HDF, and an 
LPPXQREORWWHG IRU Į60$ ZLWK D ȕ-actin loading control (B and H).  ****p<0.0001, 
***p<0.001, **p<0.01 using a pDLUHG WZR WDLOHG VWXGHQW¶V W-test. All n=3, biological 
replicates in fibroblast strain indicated above, except (f) where each the migration 
assay for each CAF was performed twice. 
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